泰林生物 (300813.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(泰林生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2022年中报2022年一季报2021年年报2021年三季报2021年中报2021年一季报2020年年报2020年三季报2020年中报2020年一季报
主要指标:
 营业收入(元) 145,700,077.6771,534,758.17283,248,491.21182,460,728.75111,038,403.4648,043,207.85200,237,532.32133,985,425.7586,201,879.2540,755,733.60
 营业利润(元) 33,376,844.9414,799,499.5169,793,470.3446,898,387.0630,769,468.7510,868,948.8751,930,223.5334,074,098.9918,536,345.698,500,933.64
 利润总额(元) 33,440,712.7214,890,543.3569,643,978.8746,873,705.9030,752,870.7710,900,775.6651,726,923.1733,970,207.5418,356,534.588,334,480.01
 净利润(元) 31,298,802.5613,925,179.0863,529,851.1042,375,107.1427,653,823.479,598,366.3148,385,613.2632,695,397.0018,295,511.157,347,252.02
 归属于母公司股东的净利润(元) 31,298,802.5613,925,179.0863,529,851.1042,375,107.1427,653,823.479,598,366.3148,385,613.2632,695,397.0018,295,511.157,347,252.02
盈利能力:
 销售毛利率(%) 57.9256.6561.8862.9064.1862.1362.8764.6865.1564.65
 销售净利率(%) 21.4819.4722.4323.2224.9019.9824.1624.4021.2218.03
 净资产收益率(%) 5.982.6913.499.276.322.16----
 总资产报酬率ROA(%) 4.081.7310.557.264.811.77----
 投入资本回报率ROIC(%) 5.082.2713.379.096.092.1314.319.915.692.21
营运能力:
 存货周转率(次) 0.510.301.160.760.560.28----
 应收账款周转率(次) 4.512.4910.056.783.532.18----
 总资产周转率(次) 0.200.100.470.330.210.09----
偿债能力:
 资产负债率(%) 32.5332.8924.1620.5618.6516.9917.7312.4011.689.83
 股东权益比率(%) 67.4767.1175.8479.4481.3583.0182.2787.6088.3290.17
 已获利息倍数(倍) -6.99-4.58-9.58-5.77-4.25-5.11-6.79-7.30-5.16-7.73
 流动比率 5.245.023.353.884.244.684.486.216.487.76
 速动比率 4.024.022.442.783.243.663.705.055.436.58
发展能力:
 营业收入增长率(%) 31.2248.9041.4636.1828.8117.8810.678.804.333.62
 营业利润增长率(%) 8.4736.1634.4037.6466.0027.8635.5416.74-5.2747.40
 税后利润增长率(%) 13.1845.0831.3029.6151.1530.6440.6329.0711.8845.69
 净资产增长率(%) 26.7928.1511.9613.0911.434.4893.9094.9696.23-
 总资产增长率(%) 52.8858.5321.4624.7120.9813.49102.3187.3490.82-

前瞻产业研究院